Diferencia entre revisiones de «Short bowel syndrome»

Sin resumen de edición
(Formatting: removed excessive bold)
Línea 2: Línea 2:
*Short bowel syndrome (SBS) is a malabsorptive condition resulting from the loss of functional small intestinal length or absorptive capacity, typically defined as '''< 200 cm of remaining small bowel''' in adults (normal length 275–850 cm)<ref name="statpearls">Short Bowel Syndrome. In: ''StatPearls''. Treasure Island (FL): StatPearls Publishing; 2023. PMID 30860742.</ref>
*Short bowel syndrome (SBS) is a malabsorptive condition resulting from the loss of functional small intestinal length or absorptive capacity, typically defined as '''< 200 cm of remaining small bowel''' in adults (normal length 275–850 cm)<ref name="statpearls">Short Bowel Syndrome. In: ''StatPearls''. Treasure Island (FL): StatPearls Publishing; 2023. PMID 30860742.</ref>
*Results in '''intestinal failure''' when the remaining bowel cannot sustain nutritional, fluid, and electrolyte needs without parenteral support
*Results in '''intestinal failure''' when the remaining bowel cannot sustain nutritional, fluid, and electrolyte needs without parenteral support
*'''Etiologies in adults:'''
*Etiologies in adults:
**Crohn's disease (most common cause requiring repeated resections)
**Crohn's disease (most common cause requiring repeated resections)
**Mesenteric ischemia / mesenteric vascular occlusion
**Mesenteric ischemia / mesenteric vascular occlusion
Línea 10: Línea 10:
**Surgical complications / adhesive small bowel obstruction requiring resection
**Surgical complications / adhesive small bowel obstruction requiring resection
**Malignancy
**Malignancy
*'''Etiologies in children:'''
*Etiologies in children:
**Necrotizing enterocolitis (NEC) — most common neonatal cause
**Necrotizing enterocolitis (NEC) — most common neonatal cause
**Intestinal atresia / congenital malformations
**Intestinal atresia / congenital malformations
**Midgut volvulus
**Midgut volvulus
**Gastroschisis
**Gastroschisis
*'''Anatomy determines clinical consequences:'''<ref name="bering">Bering J, DiBaise JK. Short bowel syndrome: complications and management. ''Nutr Clin Pract''. 2023;38(S1):S46-S58. PMID 37115034.</ref>
*Anatomy determines clinical consequences:<ref name="bering">Bering J, DiBaise JK. Short bowel syndrome: complications and management. ''Nutr Clin Pract''. 2023;38(S1):S46-S58. PMID 37115034.</ref>
**'''Jejunum-colon anastomosis''' (colon in continuity): Better prognosis; colon absorbs water, electrolytes, and short-chain fatty acids from bacterial carbohydrate fermentation; at risk for [[D-lactic acidosis|D-lactic acidosis]] and oxalate kidney stones
**Jejunum-colon anastomosis (colon in continuity): Better prognosis; colon absorbs water, electrolytes, and short-chain fatty acids from bacterial carbohydrate fermentation; at risk for [[D-lactic acidosis|D-lactic acidosis]] and oxalate kidney stones
**'''End-jejunostomy''' (no colon in continuity): Higher fluid/electrolyte losses; greater dependence on parenteral nutrition; at risk for dehydration and sodium depletion
**End-jejunostomy (no colon in continuity): Higher fluid/electrolyte losses; greater dependence on parenteral nutrition; at risk for dehydration and sodium depletion
**'''Ileal resection:''' Loss of vitamin B12 absorption (terminal ileum) and bile salt reabsorption → bile salt diarrhea and fat malabsorption
**Ileal resection: Loss of vitamin B12 absorption (terminal ileum) and bile salt reabsorption → bile salt diarrhea and fat malabsorption
**'''Ileocecal valve loss:''' Increases bacterial overgrowth and accelerates transit
**Ileocecal valve loss: Increases bacterial overgrowth and accelerates transit
*Bowel length thresholds for parenteral nutrition dependence:<ref name="statpearls"/>
*Bowel length thresholds for parenteral nutrition dependence:<ref name="statpearls"/>
**> 180 cm: Generally no PN needed
**> 180 cm: Generally no PN needed
Línea 25: Línea 25:
**< 90 cm: Prolonged or lifelong PN likely
**< 90 cm: Prolonged or lifelong PN likely
**< 60 cm: Almost always requires lifelong PN or transplant consideration
**< 60 cm: Almost always requires lifelong PN or transplant consideration
*'''Intestinal adaptation''' occurs over 1–2 years after resection: villous hyperplasia, crypt deepening, bowel dilation → gradual improvement in absorptive capacity
*Intestinal adaptation occurs over 1–2 years after resection: villous hyperplasia, crypt deepening, bowel dilation → gradual improvement in absorptive capacity


==Clinical Features==
==Clinical Features==
===Chronic / Baseline Symptoms===
===Chronic / Baseline Symptoms===
*'''Diarrhea / steatorrhea''' — high-volume, watery; may be > 2 L/day with end-jejunostomy
*Diarrhea / steatorrhea — high-volume, watery; may be > 2 L/day with end-jejunostomy
*'''Malnutrition and weight loss'''
*Malnutrition and weight loss
*'''Dehydration''' and '''electrolyte derangements''' (hyponatremia, hypokalemia, hypomagnesemia, hypocalcemia)
*Dehydration and '''electrolyte derangements''' (hyponatremia, hypokalemia, hypomagnesemia, hypocalcemia)
*Fatigue, weakness
*Fatigue, weakness
*Abdominal distension, bloating, cramping
*Abdominal distension, bloating, cramping
Línea 37: Línea 37:


===Complications Presenting to the ED===
===Complications Presenting to the ED===
*'''Severe dehydration / electrolyte crisis:'''<ref name="bering"/>
*Severe dehydration / electrolyte crisis:<ref name="bering"/>
**Hyponatremia, hypokalemia, hypomagnesemia (often refractory — Mg must be corrected before K will correct)
**Hyponatremia, hypokalemia, hypomagnesemia (often refractory — Mg must be corrected before K will correct)
**Metabolic acidosis (bicarbonate losses from high-output stoma/diarrhea) or metabolic alkalosis (dehydration, acid loss from vomiting)
**Metabolic acidosis (bicarbonate losses from high-output stoma/diarrhea) or metabolic alkalosis (dehydration, acid loss from vomiting)
**Hypocalcemia (from vitamin D malabsorption and hypomagnesemia)
**Hypocalcemia (from vitamin D malabsorption and hypomagnesemia)
*'''Central line complications''' (most SBS patients have long-term central venous catheters for parenteral nutrition):
*Central line complications (most SBS patients have long-term central venous catheters for parenteral nutrition):
**'''Catheter-related bloodstream infection (CRBSI):''' Most common life-threatening complication of PN; presents with fever, chills, rigors temporally related to PN infusion<ref name="bering"/>
**Catheter-related bloodstream infection (CRBSI): Most common life-threatening complication of PN; presents with fever, chills, rigors temporally related to PN infusion<ref name="bering"/>
**Central line thrombosis / occlusion
**Central line thrombosis / occlusion
**Catheter malposition, fracture, air embolism
**Catheter malposition, fracture, air embolism
*'''[[D-lactic acidosis]]:''' Anion gap metabolic acidosis + encephalopathy (confusion, ataxia, slurred speech) after high-carbohydrate meals; occurs in patients with colon in continuity
*[[D-lactic acidosis]]: Anion gap metabolic acidosis + encephalopathy (confusion, ataxia, slurred speech) after high-carbohydrate meals; occurs in patients with colon in continuity
*'''Small intestinal bacterial overgrowth (SIBO):''' Bloating, diarrhea worsening, abdominal pain, malodorous gas; may cause fever and elevated WBC
*Small intestinal bacterial overgrowth (SIBO): Bloating, diarrhea worsening, abdominal pain, malodorous gas; may cause fever and elevated WBC
*'''Intestinal failure–associated liver disease (IFALD):''' Jaundice, hepatomegaly, elevated LFTs; related to chronic PN use
*Intestinal failure–associated liver disease (IFALD): Jaundice, hepatomegaly, elevated LFTs; related to chronic PN use
*'''Cholelithiasis:''' SBS patients (especially < 180 cm with absent ileocecal valve) have increased risk of calcium bilirubinate gallstones → [[Cholecystitis|cholecystitis]], [[Choledocholithiasis|choledocholithiasis]]
*Cholelithiasis: SBS patients (especially < 180 cm with absent ileocecal valve) have increased risk of calcium bilirubinate gallstones → [[Cholecystitis|cholecystitis]], [[Choledocholithiasis|choledocholithiasis]]
*'''Oxalate nephrolithiasis / nephropathy:''' Hyperoxaluria occurs when unabsorbed fatty acids bind calcium, leaving oxalate free for colonic absorption → calcium oxalate [[Renal stone|kidney stones]]
*Oxalate nephrolithiasis / nephropathy: Hyperoxaluria occurs when unabsorbed fatty acids bind calcium, leaving oxalate free for colonic absorption → calcium oxalate [[Renal stone|kidney stones]]
*'''Metabolic bone disease:''' Osteoporosis/osteomalacia from vitamin D and calcium malabsorption → pathologic fractures
*Metabolic bone disease: Osteoporosis/osteomalacia from vitamin D and calcium malabsorption → pathologic fractures
*'''Nutritional deficiency emergencies:'''
*Nutritional deficiency emergencies:
**'''Vitamin B12 deficiency:''' Megaloblastic anemia, subacute combined degeneration of the spinal cord (from terminal ileum loss)
**Vitamin B12 deficiency: Megaloblastic anemia, subacute combined degeneration of the spinal cord (from terminal ileum loss)
**'''Thiamine deficiency:''' [[Wernicke encephalopathy]]
**Thiamine deficiency: [[Wernicke encephalopathy]]
**'''Vitamin K deficiency:''' Coagulopathy
**Vitamin K deficiency: Coagulopathy
**'''Iron deficiency anemia'''
**Iron deficiency anemia
**'''Zinc deficiency:''' Dermatitis, alopecia, impaired wound healing
**Zinc deficiency: Dermatitis, alopecia, impaired wound healing
*'''Bowel obstruction:''' From adhesions related to prior surgeries
*Bowel obstruction: From adhesions related to prior surgeries


==Differential Diagnosis==
==Differential Diagnosis==
Línea 75: Línea 75:
==Evaluation==
==Evaluation==
===Workup===
===Workup===
*'''BMP/CMP:''' Electrolytes ('''Na, K, Mg, Ca, Phos''' — all frequently abnormal), BUN/creatinine (dehydration/renal injury), bicarbonate (acidosis), glucose, liver enzymes, albumin
*BMP/CMP: Electrolytes ('''Na, K, Mg, Ca, Phos''' — all frequently abnormal), BUN/creatinine (dehydration/renal injury), bicarbonate (acidosis), glucose, liver enzymes, albumin
*'''Magnesium level:''' Often critically low; must be corrected before hypokalemia will respond to potassium replacement
*Magnesium level: Often critically low; must be corrected before hypokalemia will respond to potassium replacement
*'''CBC:''' Anemia (B12 deficiency → macrocytic; iron deficiency → microcytic), leukocytosis if infection
*CBC: Anemia (B12 deficiency → macrocytic; iron deficiency → microcytic), leukocytosis if infection
*'''Lactate:''' Evaluate for sepsis, mesenteric ischemia; remember standard assay measures only L-lactate (see [[D-lactic acidosis]])
*Lactate: Evaluate for sepsis, mesenteric ischemia; remember standard assay measures only L-lactate (see [[D-lactic acidosis]])
*'''Blood cultures''' (peripheral AND through central line if present): If fever, suspicion for CRBSI — draw paired cultures before antibiotics
*Blood cultures (peripheral AND through central line if present): If fever, suspicion for CRBSI — draw paired cultures before antibiotics
*'''Coagulation studies:''' PT/INR (vitamin K deficiency → elevated INR)
*Coagulation studies: PT/INR (vitamin K deficiency → elevated INR)
*'''Urinalysis:''' Oxalate crystals, infection
*Urinalysis: Oxalate crystals, infection
*'''VBG/ABG:''' Acid-base status
*VBG/ABG: Acid-base status
*'''LFTs:''' Evaluate for IFALD, biliary disease
*LFTs: Evaluate for IFALD, biliary disease
*'''Vitamin levels''' (if clinically indicated): B12, folate, 25-OH vitamin D, thiamine, zinc — may not be immediately available but should be sent
*Vitamin levels (if clinically indicated): B12, folate, 25-OH vitamin D, thiamine, zinc — may not be immediately available but should be sent
*'''Imaging:'''
*Imaging:
**'''Abdominal XR:''' If concern for obstruction
**Abdominal XR: If concern for obstruction
**'''CT abdomen/pelvis:''' Obstruction, abscess, mesenteric ischemia, cholecystitis
**CT abdomen/pelvis: Obstruction, abscess, mesenteric ischemia, cholecystitis
**'''Ultrasound:''' Right upper quadrant for gallbladder/biliary evaluation
**Ultrasound: Right upper quadrant for gallbladder/biliary evaluation
**'''CXR:''' If concern for line malposition, pneumothorax, aspiration
**CXR: If concern for line malposition, pneumothorax, aspiration


===Diagnosis===
===Diagnosis===
*SBS itself is a known condition — the ED role is to '''identify the acute complication''' bringing the patient in
*SBS itself is a known condition — the ED role is to '''identify the acute complication''' bringing the patient in
*'''Key diagnostic patterns in SBS patients:'''
*Key diagnostic patterns in SBS patients:
{| class="wikitable"
{| class="wikitable"
|-
|-
Línea 117: Línea 117:
==Management==
==Management==
===Dehydration / Electrolyte Crisis===
===Dehydration / Electrolyte Crisis===
*'''Aggressive IV fluid resuscitation:''' Normal saline initially; avoid hypotonic fluids (SBS patients often have chronic sodium depletion)
*Aggressive IV fluid resuscitation: Normal saline initially; avoid hypotonic fluids (SBS patients often have chronic sodium depletion)
*'''Electrolyte repletion:'''
*Electrolyte repletion:
**'''Magnesium FIRST''' — IV magnesium sulfate 2–4 g over 1–2 hours; hypokalemia and hypocalcemia are often refractory until Mg is corrected<ref name="bering"/>
**Magnesium FIRST — IV magnesium sulfate 2–4 g over 1–2 hours; hypokalemia and hypocalcemia are often refractory until Mg is corrected<ref name="bering"/>
**'''Potassium:''' IV KCl; monitor closely with serial BMPs
**Potassium: IV KCl; monitor closely with serial BMPs
**'''Calcium:''' IV calcium gluconate if symptomatic or severe; send vitamin D level
**Calcium: IV calcium gluconate if symptomatic or severe; send vitamin D level
**'''Phosphorus:''' Replete if low (especially if refeeding)
**Phosphorus: Replete if low (especially if refeeding)
*'''Oral rehydration solution (ORS):''' SBS patients benefit from glucose-sodium ORS (WHO formulation) rather than plain water, which can worsen sodium depletion
*Oral rehydration solution (ORS): SBS patients benefit from glucose-sodium ORS (WHO formulation) rather than plain water, which can worsen sodium depletion
*'''Monitor urine output''' — target > 0.5 mL/kg/hr
*Monitor urine output — target > 0.5 mL/kg/hr


===Catheter-Related Bloodstream Infection===
===Catheter-Related Bloodstream Infection===
*'''Draw blood cultures''' from the line AND a peripheral site before antibiotics
*Draw blood cultures from the line AND a peripheral site before antibiotics
*'''Empiric IV antibiotics:''' Vancomycin + gram-negative coverage (cefepime or piperacillin-tazobactam); adjust based on cultures<ref name="bering"/>
*Empiric IV antibiotics: Vancomycin + gram-negative coverage (cefepime or piperacillin-tazobactam); adjust based on cultures<ref name="bering"/>
*'''Do NOT routinely remove the line''' unless: hemodynamic instability/septic shock, tunnel infection, persistent bacteremia > 72 hours on appropriate antibiotics, or fungemia
*'''Do NOT routinely remove the line''' unless: hemodynamic instability/septic shock, tunnel infection, persistent bacteremia > 72 hours on appropriate antibiotics, or fungemia
*These patients have '''limited venous access''' — line preservation is critical when possible; consult the patient's PN team or vascular access specialist
*These patients have '''limited venous access''' — line preservation is critical when possible; consult the patient's PN team or vascular access specialist
Línea 140: Línea 140:


===Nutritional Deficiency Emergencies===
===Nutritional Deficiency Emergencies===
*'''Vitamin K deficiency (elevated INR):''' IV vitamin K 10 mg; FFP or PCC if actively bleeding
*Vitamin K deficiency (elevated INR): IV vitamin K 10 mg; FFP or PCC if actively bleeding
*'''Wernicke encephalopathy:''' IV thiamine 500 mg TID × 3 days (high-dose protocol)
*Wernicke encephalopathy: IV thiamine 500 mg TID × 3 days (high-dose protocol)
*'''B12 deficiency:''' IM cyanocobalamin 1,000 mcg
*B12 deficiency: IM cyanocobalamin 1,000 mcg
*'''Iron deficiency:''' IV iron infusion (in consultation with GI/hematology)
*Iron deficiency: IV iron infusion (in consultation with GI/hematology)


===General Principles===
===General Principles===
*'''Contact the patient's GI/nutrition/intestinal rehabilitation team''' early — these patients often have complex management plans and established relationships with specialists
*'''Contact the patient's GI/nutrition/intestinal rehabilitation team''' early — these patients often have complex management plans and established relationships with specialists
*'''Do not discontinue or modify parenteral nutrition''' without specialist guidance
*'''Do not discontinue or modify parenteral nutrition''' without specialist guidance
*'''Loperamide / codeine phosphate:''' May be used to reduce stoma/stool output (often part of home regimen)
*Loperamide / codeine phosphate: May be used to reduce stoma/stool output (often part of home regimen)
*'''PPI / H2 blocker:''' Reduce gastric hypersecretion that occurs in SBS (especially in the first 6–12 months)
*PPI / H2 blocker: Reduce gastric hypersecretion that occurs in SBS (especially in the first 6–12 months)


==Disposition==
==Disposition==
*'''Admit:'''
*Admit:
**Suspected CRBSI / sepsis
**Suspected CRBSI / sepsis
**Severe dehydration requiring IV repletion > 24 hours
**Severe dehydration requiring IV repletion > 24 hours
Línea 160: Línea 160:
**Symptomatic nephrolithiasis requiring urologic intervention
**Symptomatic nephrolithiasis requiring urologic intervention
**Severe nutritional deficiency emergencies (Wernicke, severe B12 deficiency with neurologic involvement)
**Severe nutritional deficiency emergencies (Wernicke, severe B12 deficiency with neurologic involvement)
*'''ICU admission:'''
*ICU admission:
**Septic shock from CRBSI
**Septic shock from CRBSI
**Severe metabolic derangement with hemodynamic instability
**Severe metabolic derangement with hemodynamic instability
**Altered mental status (D-lactic acidosis, Wernicke, severe electrolyte abnormality)
**Altered mental status (D-lactic acidosis, Wernicke, severe electrolyte abnormality)
*'''Discharge with close follow-up:'''
*Discharge with close follow-up:
**Mild dehydration responding to oral/IV rehydration in the ED
**Mild dehydration responding to oral/IV rehydration in the ED
**Mild electrolyte abnormalities corrected in the ED with reliable outpatient follow-up
**Mild electrolyte abnormalities corrected in the ED with reliable outpatient follow-up

Revisión del 16:12 19 mar 2026

Background

  • Short bowel syndrome (SBS) is a malabsorptive condition resulting from the loss of functional small intestinal length or absorptive capacity, typically defined as < 200 cm of remaining small bowel in adults (normal length 275–850 cm)[1]
  • Results in intestinal failure when the remaining bowel cannot sustain nutritional, fluid, and electrolyte needs without parenteral support
  • Etiologies in adults:
    • Crohn's disease (most common cause requiring repeated resections)
    • Mesenteric ischemia / mesenteric vascular occlusion
    • Radiation enteritis
    • Volvulus
    • Trauma (penetrating abdominal trauma with bowel loss)
    • Surgical complications / adhesive small bowel obstruction requiring resection
    • Malignancy
  • Etiologies in children:
    • Necrotizing enterocolitis (NEC) — most common neonatal cause
    • Intestinal atresia / congenital malformations
    • Midgut volvulus
    • Gastroschisis
  • Anatomy determines clinical consequences:[2]
    • Jejunum-colon anastomosis (colon in continuity): Better prognosis; colon absorbs water, electrolytes, and short-chain fatty acids from bacterial carbohydrate fermentation; at risk for D-lactic acidosis and oxalate kidney stones
    • End-jejunostomy (no colon in continuity): Higher fluid/electrolyte losses; greater dependence on parenteral nutrition; at risk for dehydration and sodium depletion
    • Ileal resection: Loss of vitamin B12 absorption (terminal ileum) and bile salt reabsorption → bile salt diarrhea and fat malabsorption
    • Ileocecal valve loss: Increases bacterial overgrowth and accelerates transit
  • Bowel length thresholds for parenteral nutrition dependence:[1]
    • > 180 cm: Generally no PN needed
    • 90–180 cm: PN usually needed for < 1 year
    • < 90 cm: Prolonged or lifelong PN likely
    • < 60 cm: Almost always requires lifelong PN or transplant consideration
  • Intestinal adaptation occurs over 1–2 years after resection: villous hyperplasia, crypt deepening, bowel dilation → gradual improvement in absorptive capacity

Clinical Features

Chronic / Baseline Symptoms

  • Diarrhea / steatorrhea — high-volume, watery; may be > 2 L/day with end-jejunostomy
  • Malnutrition and weight loss
  • Dehydration and electrolyte derangements (hyponatremia, hypokalemia, hypomagnesemia, hypocalcemia)
  • Fatigue, weakness
  • Abdominal distension, bloating, cramping
  • Peripheral edema (hypoalbuminemia)

Complications Presenting to the ED

  • Severe dehydration / electrolyte crisis:[2]
    • Hyponatremia, hypokalemia, hypomagnesemia (often refractory — Mg must be corrected before K will correct)
    • Metabolic acidosis (bicarbonate losses from high-output stoma/diarrhea) or metabolic alkalosis (dehydration, acid loss from vomiting)
    • Hypocalcemia (from vitamin D malabsorption and hypomagnesemia)
  • Central line complications (most SBS patients have long-term central venous catheters for parenteral nutrition):
    • Catheter-related bloodstream infection (CRBSI): Most common life-threatening complication of PN; presents with fever, chills, rigors temporally related to PN infusion[2]
    • Central line thrombosis / occlusion
    • Catheter malposition, fracture, air embolism
  • D-lactic acidosis: Anion gap metabolic acidosis + encephalopathy (confusion, ataxia, slurred speech) after high-carbohydrate meals; occurs in patients with colon in continuity
  • Small intestinal bacterial overgrowth (SIBO): Bloating, diarrhea worsening, abdominal pain, malodorous gas; may cause fever and elevated WBC
  • Intestinal failure–associated liver disease (IFALD): Jaundice, hepatomegaly, elevated LFTs; related to chronic PN use
  • Cholelithiasis: SBS patients (especially < 180 cm with absent ileocecal valve) have increased risk of calcium bilirubinate gallstones → cholecystitis, choledocholithiasis
  • Oxalate nephrolithiasis / nephropathy: Hyperoxaluria occurs when unabsorbed fatty acids bind calcium, leaving oxalate free for colonic absorption → calcium oxalate kidney stones
  • Metabolic bone disease: Osteoporosis/osteomalacia from vitamin D and calcium malabsorption → pathologic fractures
  • Nutritional deficiency emergencies:
    • Vitamin B12 deficiency: Megaloblastic anemia, subacute combined degeneration of the spinal cord (from terminal ileum loss)
    • Thiamine deficiency: Wernicke encephalopathy
    • Vitamin K deficiency: Coagulopathy
    • Iron deficiency anemia
    • Zinc deficiency: Dermatitis, alopecia, impaired wound healing
  • Bowel obstruction: From adhesions related to prior surgeries

Differential Diagnosis

Evaluation

Workup

  • BMP/CMP: Electrolytes (Na, K, Mg, Ca, Phos — all frequently abnormal), BUN/creatinine (dehydration/renal injury), bicarbonate (acidosis), glucose, liver enzymes, albumin
  • Magnesium level: Often critically low; must be corrected before hypokalemia will respond to potassium replacement
  • CBC: Anemia (B12 deficiency → macrocytic; iron deficiency → microcytic), leukocytosis if infection
  • Lactate: Evaluate for sepsis, mesenteric ischemia; remember standard assay measures only L-lactate (see D-lactic acidosis)
  • Blood cultures (peripheral AND through central line if present): If fever, suspicion for CRBSI — draw paired cultures before antibiotics
  • Coagulation studies: PT/INR (vitamin K deficiency → elevated INR)
  • Urinalysis: Oxalate crystals, infection
  • VBG/ABG: Acid-base status
  • LFTs: Evaluate for IFALD, biliary disease
  • Vitamin levels (if clinically indicated): B12, folate, 25-OH vitamin D, thiamine, zinc — may not be immediately available but should be sent
  • Imaging:
    • Abdominal XR: If concern for obstruction
    • CT abdomen/pelvis: Obstruction, abscess, mesenteric ischemia, cholecystitis
    • Ultrasound: Right upper quadrant for gallbladder/biliary evaluation
    • CXR: If concern for line malposition, pneumothorax, aspiration

Diagnosis

  • SBS itself is a known condition — the ED role is to identify the acute complication bringing the patient in
  • Key diagnostic patterns in SBS patients:
Presentation Likely Complication
Fever + rigors during or after PN infusion CRBSI — draw blood cultures (line and peripheral)
AGMA + normal L-lactate + encephalopathy after carbs D-lactic acidosis — send D-lactate level
Refractory hypokalemia despite IV K replacement Hypomagnesemia — check and replace Mg first
Elevated INR + easy bruising, no anticoagulant use Vitamin K deficiency — give IV vitamin K
Flank pain + hematuria Oxalate nephrolithiasis — CT KUB
Ataxia, confusion, ophthalmoplegia Wernicke encephalopathy — give IV thiamine empirically
Macrocytic anemia + neurologic symptoms B12 deficiency — send B12 level, IM cyanocobalamin
High-output stoma with hypotension, tachycardia Dehydration/electrolyte crisis — aggressive IV resuscitation

Management

Dehydration / Electrolyte Crisis

  • Aggressive IV fluid resuscitation: Normal saline initially; avoid hypotonic fluids (SBS patients often have chronic sodium depletion)
  • Electrolyte repletion:
    • Magnesium FIRST — IV magnesium sulfate 2–4 g over 1–2 hours; hypokalemia and hypocalcemia are often refractory until Mg is corrected[2]
    • Potassium: IV KCl; monitor closely with serial BMPs
    • Calcium: IV calcium gluconate if symptomatic or severe; send vitamin D level
    • Phosphorus: Replete if low (especially if refeeding)
  • Oral rehydration solution (ORS): SBS patients benefit from glucose-sodium ORS (WHO formulation) rather than plain water, which can worsen sodium depletion
  • Monitor urine output — target > 0.5 mL/kg/hr

Catheter-Related Bloodstream Infection

  • Draw blood cultures from the line AND a peripheral site before antibiotics
  • Empiric IV antibiotics: Vancomycin + gram-negative coverage (cefepime or piperacillin-tazobactam); adjust based on cultures[2]
  • Do NOT routinely remove the line unless: hemodynamic instability/septic shock, tunnel infection, persistent bacteremia > 72 hours on appropriate antibiotics, or fungemia
  • These patients have limited venous access — line preservation is critical when possible; consult the patient's PN team or vascular access specialist

D-Lactic Acidosis

  • NPO / fasting (eliminate carbohydrate substrate)
  • IV sodium bicarbonate for significant acidosis
  • IV thiamine 100 mg empirically
  • Enteral antibiotics (metronidazole, oral vancomycin)
  • See D-lactic acidosis for full management

Nutritional Deficiency Emergencies

  • Vitamin K deficiency (elevated INR): IV vitamin K 10 mg; FFP or PCC if actively bleeding
  • Wernicke encephalopathy: IV thiamine 500 mg TID × 3 days (high-dose protocol)
  • B12 deficiency: IM cyanocobalamin 1,000 mcg
  • Iron deficiency: IV iron infusion (in consultation with GI/hematology)

General Principles

  • Contact the patient's GI/nutrition/intestinal rehabilitation team early — these patients often have complex management plans and established relationships with specialists
  • Do not discontinue or modify parenteral nutrition without specialist guidance
  • Loperamide / codeine phosphate: May be used to reduce stoma/stool output (often part of home regimen)
  • PPI / H2 blocker: Reduce gastric hypersecretion that occurs in SBS (especially in the first 6–12 months)

Disposition

  • Admit:
    • Suspected CRBSI / sepsis
    • Severe dehydration requiring IV repletion > 24 hours
    • Significant electrolyte derangements (symptomatic hyponatremia, hypokalemia, hypomagnesemia)
    • D-lactic acidosis with encephalopathy
    • Bowel obstruction
    • Symptomatic nephrolithiasis requiring urologic intervention
    • Severe nutritional deficiency emergencies (Wernicke, severe B12 deficiency with neurologic involvement)
  • ICU admission:
    • Septic shock from CRBSI
    • Severe metabolic derangement with hemodynamic instability
    • Altered mental status (D-lactic acidosis, Wernicke, severe electrolyte abnormality)
  • Discharge with close follow-up:
    • Mild dehydration responding to oral/IV rehydration in the ED
    • Mild electrolyte abnormalities corrected in the ED with reliable outpatient follow-up
    • Ensure the patient's GI/nutrition team is contacted and aware of the ED visit
    • Provide ORS instructions and dietary counseling

See Also

External Links

References

  1. 1.0 1.1 Short Bowel Syndrome. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. PMID 30860742.
  2. 2.0 2.1 2.2 2.3 2.4 Bering J, DiBaise JK. Short bowel syndrome: complications and management. Nutr Clin Pract. 2023;38(S1):S46-S58. PMID 37115034.